Article
A National Multicenter Evaluation of the Clinical Utility of Optical Genome Mapping for Assessment of Genomic Aberrations in Acute Myeloid Leukemia
2020-11-10
Abstract excerpt
Detection of hallmark genomic aberrations in acute myeloid leukemia (AML) is essential for prognosis and patient management. Clinical practice guidelines for identifying such structural variants (SVs), established by the World Health Organization (WHO), European Leukemia Net (ELN) and National Comprehensive Cancer Network (NCCN), rely substantially on cytogenetic/cytogenomic techniques such as karyotyping, fluores...
Topics
Open a Topic to create a Post that cites this publication.
- Acute Lymphoblastic Leukemia research
- Acute Myeloid Leukemia Research
- Advanced biosensing and bioanalysis techniques
- Cancer Genomics and Diagnostics
- Chronic Lymphocytic Leukemia Research
- Genomic variations and chromosomal abnormalities
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
Identifiers and source
- Literature Corpus work
- 2c2c163a-eae3-5425-8cb0-4dfb98cdbbad
- DOI
- 10.1101/2020.11.07.20227728
